
|Articles|May 1, 2002
- Volume 0 0
Laughter: Not the Best Medicine for Asthmatic Kids?
Advertisement
Laughter may not be the best medicine for children with asthma, a new study has shown. A review of all children presenting to an emergency department for an asthma attack during a 6-month period showed that laughter is more likely to cause an asthma attack than is exercise or air pollution. In fact, almost 33% of asthma attacks in these children were triggered by laughter. The study investigators believe that laughter-induced asthma attacks can be avoided if a child?s asthma is managed properly.
Articles in this issue
over 24 years ago
HOT OTC Introductions in 2001over 24 years ago
Making the "White" Choice: OTC Tooth-Whitening Productsover 24 years ago
Norelgestromin/ Ethinyl Estradiol (Ortho Evra)over 24 years ago
Lawyers Have Latitude in Closing Argumentsover 24 years ago
Incomplete Directions Can Lead to Dispensing Errorsover 24 years ago
Pharmacodynamic Drug Interactions with Ziprasidoneover 24 years ago
An Update on Hepatitis Cover 24 years ago
Medication Advice for Travelersover 24 years ago
Allergic Rhinitis: A Focus on Nonprescription Therapyover 24 years ago
Animal Protein May Protect Bone Mineral DensityAdvertisement
Related to this article

In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.

Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.

Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
2
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
3
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
4
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
5

